Literature DB >> 9542917

Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts.

S K Fridkin1, D S Yokoe, C G Whitney, A Onderdonk, D C Hooper.   

Abstract

In 1996, the dominant (43%) strain of vancomycin-resistant enterococci (VRE; type A) at Massachusetts General Hospital was identified at Brigham and Women's Hospital (BWH). To characterize the epidemiology of infection with type A isolates of VRE at BWH, we collected demographic and clinical data for all patients from whom VRE were isolated from a clinical specimen through September 1996. The first clinical isolates from all BWH patients from whom VRE were isolated were typed by pulsed-field gel electrophoresis of SmaI digests of chromosomal DNA. Among patients hospitalized after the first patient at BWH infected with a type A isolate of VRE was identified, exposures were compared between patients who acquired type A isolates of VRE and those who acquired other types of VRE. Isolates from 99 patients identified to have acquired VRE were most commonly from blood (n = 27), urine (n = 19), or wounds (n = 19). Three months after the index patient arrived at BWH and at a time when > or =12 types of strains of VRE were present, type A isolates of VRE became dominant; 39 of 75 (52%) of the study cohort had acquired type A isolates of VRE. We found no association between the acquisition of type A isolates of VRE and transfer from another institution or temporal overlap by service, ward, or floor with patients known to have acquired type A isolates of VRE. By multivariate analysis, only residence in the medical intensive care unit (adjusted odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4 to 107) and the receipt of two or more antibiotics per patient-day (adjusted OR, 12.2; 95% CI, 1.2 to 9.0) were associated with the acquisition of strain A. This strain of VRE, dominant at two Boston hospitals, was associated with intensity of antibiotic exposures (i.e., two or more antibiotics per patient-day). We hypothesize that this strain may have unidentified properties providing a mechanism favoring its spread and dominance over other extant isolates, and further studies are needed to define these properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542917      PMCID: PMC104669          DOI: 10.1128/JCM.36.4.965-970.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.

Authors:  B E Murray; K V Singh; J D Heath; B R Sharma; G M Weinstock
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.

Authors:  L V Karanfil; M Murphy; A Josephson; R Gaynes; L Mandel; B C Hill; J M Swenson
Journal:  Infect Control Hosp Epidemiol       Date:  1992-04       Impact factor: 3.254

3.  Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital.

Authors:  D A Pegues; C F Pegues; P L Hibberd; D S Ford; D C Hooper
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers.

Authors:  L L Livornese; S Dias; C Samel; B Romanowski; S Taylor; P May; P Pitsakis; G Woods; D Kaye; M E Levison
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

5.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.

Authors:  S Handwerger; B Raucher; D Altarac; J Monka; S Marchione; K V Singh; B E Murray; J Wolff; B Walters
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

6.  Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas.

Authors:  S M Donabedian; J W Chow; J M Boyce; R E McCabe; S M Markowitz; P E Coudron; A Kuritza; C L Pierson; M J Zervos
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

7.  Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.

Authors:  M A Montecalvo; H Horowitz; C Gedris; C Carbonaro; F C Tenover; A Issah; P Cook; G P Wormser
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

8.  Vancomycin-resistant Enterococcus faecium in hospitalized children.

Authors:  L G Rubin; V Tucci; E Cercenado; G Eliopoulos; H D Isenberg
Journal:  Infect Control Hosp Epidemiol       Date:  1992-12       Impact factor: 3.254

9.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.

Authors:  J M Boyce; S M Opal; J W Chow; M J Zervos; G Potter-Bynoe; C B Sherman; R L Romulo; S Fortna; A A Medeiros
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.

Authors:  J W Chow; A Kuritza; D M Shlaes; M Green; D F Sahm; M J Zervos
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more
  9 in total

1.  Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.

Authors:  W E Bischoff; T M Reynolds; G O Hall; R P Wenzel; M B Edmond
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci.

Authors:  D Turabelidze; M Kotetishvili; A Kreger; J G Morris; A Sulakvelidze
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa.

Authors:  A von Gottberg; W van Nierop; A Dusé; M Kassel; K McCarthy; A Brink; M Meyers; R Smego; H Koornhof
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.

Authors:  E M Mascini; K P Jalink; T E M Kamp-Hopmans; H E M Blok; J Verhoef; M J M Bonten; A Troelstra
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital.

Authors:  A N Maniatis; S Pournaras; M Kanellopoulou; F Kontos; E Dimitroulia; E Papafrangas; A Tsakris
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Intraspecies genomic groups in Enterococcus faecium and their correlation with origin and pathogenicity.

Authors:  Marc Vancanneyt; Angiolella Lombardi; Christian Andrighetto; Edo Knijff; Sandra Torriani; K Johanna Björkroth; Charles M A P Franz; María R Foulquié Moreno; Hilde Revets; Luc De Vuyst; Jean Swings; Karel Kersters; Franco Dellaglio; Wilhelm H Holzapfel
Journal:  Appl Environ Microbiol       Date:  2002-03       Impact factor: 4.792

7.  The A, B, BI, and Cs of Clostridium difficile.

Authors:  Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

8.  Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course.

Authors:  Jin-Hong Yoo; Dong-Gun Lee; Su Mi Choi; Jung-Hyun Choi; Wan-Shik Shin; Myungshin Kim; Dongeun Yong; Kyungwon Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt.

Authors:  Dalia Moemen; Doaa Tawfeek; Wafaa Badawy
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.